China Drug List Seen Boosting Western Firms' Sales

16.03.2010 - Chinese plans to broaden the list of medicines eligible for a rebate from July will benefit Western drugmakers such as AstraZeneca and Sanofi-Aventis, according to Morgan Stanley...